

#58305
Mentioned in 1 episodes
For Blood and Money
Billionaires, Biotech, and the Quest for a Blockbuster Drug
Book • 2023
For Blood and Money tells the story of an upstart biotechnology company in California that developed a one-in-a-million cancer drug using a BTK inhibitor, which showed remarkable efficacy in treating a vicious type of leukemia.
The book delves into the world of biotech start-ups, detailing the roles of scientists, doctors, investors, and patients in the high-stakes game of drug development.
It explores the complexities of bringing new drugs to market, the reasons behind their high costs, and the influence of profit-driven venture capitalists on the future of medicine.
The book delves into the world of biotech start-ups, detailing the roles of scientists, doctors, investors, and patients in the high-stakes game of drug development.
It explores the complexities of bringing new drugs to market, the reasons behind their high costs, and the influence of profit-driven venture capitalists on the future of medicine.
Mentioned by
Mentioned in 1 episodes
Mentioned by 

when discussing the challenges in the therapeutics world.


Patrick O'Shaughnessy

188 snips
Tal Zaks - Bridging Science, Medicine, and Returns - [Invest Like the Best, EP.406]
Mentioned by ![undefined]()

in reference to the story of Keytruda being shelved before eventually seeing success.

Jon Chee

🧬 Why Drug Discovery Takes 15 Years (And How AI Cuts It to 3) | Andrey Doronichev (Part 4/4)